Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer

NCT02254278 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02254278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02254278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Trial for Patients With p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer
Lead sponsor
NRG Oncology
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2014
Completion date
September 4, 2025
Enrollment
316 (actual)
Sites
222

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii oropharyngeal squamous cell carcinoma, stage iva oropharyngeal squamous cell carcinoma, stage ivb oropharyngeal squamous cell carcinoma, stage ivc oropharyngeal squamous cell carcinoma, tongue carcinoma